The EMA has started a review of a regimen based on Pfizer and Astellas' Padcev and MSD's Keytruda that has been described as ...

In the 104-patient, phase 3 trial, a daily oral dose of tinlarebant achieved the primary efficacy endpoint by demonstrating a ...

The five-year SURMOUNT-REAL UK trial, part of a collaboration signed last year between Lilly and the UK government, will ...

The source of the reports is an internal email to CBER staff in which Prasad said that, in a "profound revelation," the US ...

The Clinical Data Research Report shows data managers are currently losing an estimated 12 hours per week per study to ...

Prostate cancer screening should not be made available to the vast majority of men across the UK, according to a committee set up to recommend a screening policy for the health service.

Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...

The federal government shutdown meant that the Securities & Exchange Commission (SEC), which oversees listing processes in ...

A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for ...

The FDA has started a priority review of BeOne Medicines' BCL2 inhibitor sonrotoclax in relapsed or refractory mantle cell ...

J&J is also running mid-stage trials of a tau active immunotherapy codenamed JNJ-2056 for Alzheimer's, while other active tau ...